Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing

References

• Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG. Interlaboratory comparison of Epstein–Barr virus viral load assays. Am. J. Transplant.9, 269–279 (2009).
   PubMed Web of Science ®Google Scholar
• Hayden RT, Hokanson KM, Pounds SB et al. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein–Barr virus. J. Clin. Microbiol.46, 157–163 (2008).
   PubMed Web of Science ®Google Scholar
• Wolff DJ, Heaney DL, Neuwald PD, Stelrecht KA, Press RD. Multi-site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the Association for Molecular Pathology. J. Mol. Diagn.11, 87–92 (2009).
   PubMed Web of Science ®Google Scholar
• Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaaitis JK. Interlaboratory comparison of cytomegalovirus viral load assays. Am. J. Transplantation9, 256–268 (2009).
   Google Scholar
• Ramsden SC, Deans Z, Robinson DO et al. Monitoring standards for molecular genetic testing in the United Kingdom, The Netherlands and Ireland. Genetic Testing10, 147–156 (2006).
   Google Scholar
• Bellissimo DB. Practice guidelines and proficiency testing for molecular assays. Transfusion47(1 Suppl.), 79S–84S (2007).
   Google Scholar
• ISO 15195. Laboratory medicine – Requirements for reference measurement laboratories. International Organization for Standardization, Geneva, Switzerland (2003).
   Google Scholar
• ISO 17511. In vitro diagnostic medical devices – measurement of quantities in biological samples – metrological traceability of values assigned to calibrators and control materials. International Organization for Standardization, Geneva, Switzerland (2003).
   Google Scholar
• Imperiale MJ, Major EO. Polyomaviruses. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 2265–2298 (2007).
   Google Scholar
• Pellett PR, Roizman B. The family Herpesviridae: a brief introduction. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 2479–2499 (2007).
   Google Scholar
• Wang WJ, Patterson CE, Yang SJ, Zhu H. Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. J. Virol. Methods121, 137–143 (2004).
   Google Scholar
• Kilpatrick BA, Huang ES. Human cytomegalovirus genome: partial denaturation map and organization of genome sequences. J. Virol.24, 261–276 (1977).
   PubMedGoogle Scholar
• Zhang C, Xing D. Single-molecule DNA amplification and analysis using microfluidics. Chem. Rev.110, 4910–4947 (2010).
   PubMed Web of Science ®Google Scholar
• Bhat S, Herrmann J, Armishaw P, Corbisier P, Emslie KR. Single molecule detection in nanofluidic digital array enables accurate measurement of DNA copy number. Anal. Bioanal. Chem.394, 457–467 (2009).
   PubMed Web of Science ®Google Scholar
• Corbisier P, Bhat S, Partis L, Xie VRD, Emslie KR. Absolute quantification of genetically modified MON810 maize (Zea mays L.) by digital polymerase chain reaction. Anal. Bioanal. Chem.396, 2143–2150 (2010).
   PubMed Web of Science ®Google Scholar
• Ferguson M, Heath AB. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine. Biologicals32, 195–205 (2004).
   PubMed Web of Science ®Google Scholar
• Saldanha J, Heath AB, Lelie N. WHO Collaborative Study Group: establishment of the first International Standard for nucleic acid amplification technology assays for hepatitis C virus RNA. Vox Sang.76, 149–158 (1999).
   PubMed Web of Science ®Google Scholar
• Saldanha J, Gerlich W, Lelie, N, Dawson P, Heerman K, Heath AB. WHO Collaborative Study Group: an international collaborative study to establish a World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang.80, 63–71 (2001).
   PubMed Web of Science ®Google Scholar
• Saldanha J, Heath AB, Lelie N, Pisani G, Yu MY. Collaborative Study Group: a World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays. Vox Sang.89, 52–58 (2005).
   Google Scholar
• World Health Organization: Annex 1i. Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). WHO Technical Report Series 932. World Health Organization, Geneva, Switzerland (2006).
   Google Scholar
• Wilson JA, Pratt VM, Phansalkar A et al. Consensus characterization of 16 FMR1 reference materials: a consortium study. J. Mol. Diagn.10, 2–12 (2008).
   Google Scholar
• Kalman LV, Wilson JA, Buller A et al. Characterization of genomic DNA reference materials for genetic testing of disorders common in people of Ashkenazi Jewish decent. J. Mol. Diagn.11(6), 530–536 (2009).
   Google Scholar
• Pratt VM, Caggana M, Bridges C et al. Development of genomic reference materials for cystic fibrosis genetic testing. J. Mol. Diagn.11(3), 186–193 (2009).
   PubMedGoogle Scholar
• Kalman L, Johnson MA, Beck J et al. Development of genomic reference materials for Huntington disease genetic testing. Genet. Med.9, 719–723 (2007).
   PubMed Web of Science ®Google Scholar
• Barker SD, Bale S, Buller A et al. Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. J. Mol. Diagn.11(6), 553–561 (2009).
   Google Scholar
• Kalman L, Leonard J, Gerry N et al. Quality assurance for Duchenne and Becker muscular dystrophy molecular testing: development of a genomic DNA reference material panel. J. Mol. Diagn.13(2), 167–174 (2011).
   Google Scholar
• Pratt VM, Zehnbauer N, Wilson JA et al. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GET-RM and association for molecular pathology collaborative project. J. Mol. Diagn.12(6), 835–846 (2010).
   PubMed Web of Science ®Google Scholar
• D’Hulst C, Kooy RF. Fragile X syndrome: from molecular genetics to therapy. J. Med. Genet.46(9), 577–584 (2009).
   PubMedGoogle Scholar
• Martin JB, Guesella JF. Huntington’s disease. N. Engl. J. Med.315(20), 1267–1276 (1986).
   PubMed Web of Science ®Google Scholar
• McNeil SM, Novelletto A, Srinidhi J et al. Reduced penetrance of the Huntington’s disease mutation. Hum. Mol. Genet.6(3), 775–779 (1997).
   Google Scholar
• Potter NT, Spector EB, Prior TW. Technical standards and guidelines for huntington disease. In: Standards and Guidelines for Clinical Genetic Laboratories. American College of Medical Genetics, Bethesda, MD, USA (2006).
   Google Scholar
• Tan PK, Downey TJ, Spriznagel EL Jr et al. Evaluation of gene expression measurements from commercial microarray platforms. Nuc. Acids Res.31(19), 5676–5684 (2003).
   PubMed Web of Science ®Google Scholar
• Baker SC, Bauer SR, Beyer RP et al. The external RNA controls consortium: a progress report. Nat. Methods2(10), 731–734 (2005).
   PubMed Web of Science ®Google Scholar
• Devonshire AS, Elaswarapu R, Foy CA. Evaluation of external RNA controls for the standardization of gene expression biomarker measurements. BMC Genomics11, 662 (2010).
   Google Scholar
• Hawkins M, Boyle J, Wright KE et al. Preparation and validation of the first WHO international genetic reference panel for fragile X syndrome. Eur. J. Hum. Genet.19, 10–17 (2011).
   PubMed Web of Science ®Google Scholar
• The European Union. The directive of the European parliament and of the council of 27 October 1998 on in vitro diagnostic medical devices. The Official Journal of the European Communities. L331/1-l331-37 (1998).
   Google Scholar
• ISO 15194. In vitro diagnostic medical devices – measurement of quantities in samples of biological origin – requirements for certified reference materials and the content of supporting documentation. International Organization for Standardization, Geneva, Switzerland (2009).
   Google Scholar
• ISO 17043. Conformity assessment – General requirements for proficiency testing. International Organization for Standardization, Geneva, Switzerland (2010).
   Google Scholar
• ISO 17025. General requirements for the competence of testing and calibration laboratories. International Organization for Standardization, Geneva, Switzerland (2005).
   Google Scholar
• Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ. International standards and reference materials for quantitative molecular infectious disease testing. J. Mol. Diagn.12(2), 133–143 (2010).
   PubMed Web of Science ®Google Scholar
• Recommendations for the preparation, characterization and establishment of international and other biological reference standards. WHO Technical Report Series, No. 932. World Health Organization, Geneva, Switzerland (2004).
   Google Scholar
• CLSI C53. Characterization and quantification of commutable reference materials for laboratory medicine. Clinical and Laboratory Standards Institute, PA, USA (2009).
   Google Scholar
• Caliendo AM, Shahbazian MD, Schaper C et al. Commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin. Chem.55, 1701–1710 (2009).
   PubMedGoogle Scholar
• CLSI C39. A designated comparison method for the measurement of ionized calcium in serum; approved standard. Clinical and Laboratory Standards Institute, PA, USA (2000).
   Google Scholar
• CLSI MM16-A. The use of external RNA controls in gene expression assays. Clinical and Laboratory Standards Institute, PA, USA (2006).
   Google Scholar
• Sunderman FW. The history of proficiency testing/quality control. Clin. Chem.38(7), 1205–1209 (1992).
   Google Scholar
• Best SJ, Gust AP, Johnson EIM, McGavin C, Dax EM. Quality of human deficiency virus viral load testing in Australia. J. Clin. Microbiol.38(11), 4015–4020 (2000).
   Google Scholar
• Laperche S, Bourchardeu F, Thibault F, et al. Multicenter trials need to use the same assay for hepatitis C virus viral load determination. J. Clin. Microbiol.45(11), 3788–3790 (2007).
   Google Scholar
• Schirm J, van Loon AM, Valentine-Thon GM. External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J. Clin. Virol.40, 2973–2980 (2002).
   Google Scholar
• Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS clinical trials group virology laboratories. J. Clin. Microbiol.34, 2695–2701 (1996).
   Google Scholar
• CLSI MM14-A. Proficiency testing (external quality assessment) for molecular methods. Clinical and Laboratory Standards Institute, PA, USA (2005).
   Google Scholar
• CLSI MM17. A verification and validation of multiplex nucleic acid assays. Clinical and Laboratory Standards Institute, PA, USA (2008).
   Google Scholar
• Orlando C, Verderio P et al. EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. Clin. Chem.53(7), 1349–1357 (2007).
   PubMed Web of Science ®Google Scholar
• Pandit A, MacKay WG, Steel C, van Loon AM, Schuurman R. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 genotyping proficiency programme. J. Clin. Virol.43(4), 401–406 (2008).
   PubMed Web of Science ®Google Scholar
• Meerhoff TJ, MacKay WG, Meijer A et al. The impact of laboratory characteristics on molecular detection of respiratory syncytial virus in a European multicentre quality control study. Clin. Microbiol. Infect.14, 1173–1176 (2008).
   Google Scholar
• Salit ML, Ciesiolka T, Greenberg N et al. CLSI X05R. Metrological traceability and its implementation; a report. Clinical and Laboratory Standards Institute, PA, USA (2006).
   Google Scholar
• ILAC G9. Guidelines for the selection and use of reference materials. International Laboratory Accreditation Cooperation, NSW, Australia (2005).
   Google Scholar
• CLSI MM6. Quantitative molecular methods for infectious diseases. Clinical and Laboratory Standards Institute, PA, USA (2003).
   Google Scholar
• CLSI MM10-A. Genotyping for infectious diseases: identification and characterization. Clinical and Laboratory Standards Institute, PA, USA (2006).
   Google Scholar
• Chen B, Gagnon M, Shahangian S et al. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm. Rep.58(RR-6), 1–37 (2009).
   Google Scholar